Design Therapeutics, Inc. · NASDAQ:DSGN
Logos Global Management LP reported a 4.40% stake in Design Therapeutics, Inc. (Schedule 13D/A)
Event Nov 14, 2025 · Filed Nov 18, 2025
Logos Global Management LP reported a 4.40% stake in Design Therapeutics, Inc., 2,500,000 shares, with active intent on Nov 14, 2025. Filed Nov 18, 2025 (Schedule 13D/A).
- Stake
- 4.40%
- Shares
- 2,500,000
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Logos Global Management LP | 4.40% | 2,500,000 |
| Logos Global Management GP LLC | 4.40% | 2,500,000 |
| Logos Global Master Fund LP | 2.60% | 1,500,000 |
| Logos GP LLC | 2.60% | 1,500,000 |
| Arsani William | 4.40% | 2,515,000 |
Source
Related
- Design Therapeutics, Inc.
- Logos Global Management LP
- Design Therapeutics, Inc. shareholders
- Schedule 13D/A · Logos Global Management LP · Nov 12, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jun 9, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13D/A · SR One Capital Fund I Aggregator, LP · Mar 11, 2026